Literature DB >> 22971317

Effective treatment of nodular amyloidosis with carbon dioxide laser.

Aleksandra Lesiak1, Adam Rakowski, Agnieszka Brzezinska, Michał Rogowski-Tylman, Pawel Kolano, Anna Sysa-Jedrzejowska, Joanna Narbutt.   

Abstract

BACKGROUND: Nodular amyloidosis is a rare form of localized cutaneous amyloidosis that is characterized by nodules located on the extremities, trunk, genitalia, or face. In treatment regimens, many approaches have been described, including carbon dioxide (CO2) laser therapy.
OBJECTIVE: We present a case of a 60-year-old white male with a 20-year history of disseminated waxy, purpuric, yellowish, and bullous skin lesions on the trunk and extremities. The skin changes were accompanied by pain during palpation and were temporarily pruritic.
METHOD: Based on histologic and direct immunofluorescence test findings, the diagnosis of cutaneous nodular amyloidosis was established. Skin lesions were treated with a CO2 laser. During surgery, treated tissue was found to be slightly friable, and there was a little problem with hemostasis that correlated with amyloid infiltration of the dermis and blood vessels. However, after 8 weeks, we observed clinical improvement of all treated areas with the presence of atrophic scars. In the regions of laser therapy, no recurrence of the disease was observed during a 12-month follow-up.
CONCLUSION: Based on these results, we conclude that CO2 laser has a beneficial effect in the treatment of nodular amyloidosis; however, surgery procedures may be associated sometimes with tissue friability and poor hemostasis.

Entities:  

Mesh:

Year:  2012        PMID: 22971317     DOI: 10.1177/120347541201600519

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  2 in total

Review 1.  Treatment of primary cutaneous amyloidosis with laser: a review of the literature.

Authors:  Rand S Al Yahya
Journal:  Lasers Med Sci       Date:  2016-03-16       Impact factor: 3.161

2.  Nodular cutaneous amyloidosis effectively treated with intralesional methotrexate.

Authors:  James Raymond; James Choi
Journal:  JAAD Case Rep       Date:  2016-09-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.